United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for EUPRAXIA PHARMACEUTICALS INC.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
| ROE | -564.26% | -7.91% | -8.6% | -9.42% | -10.41% | -11.64% |
|---|---|---|---|---|---|---|
| ROA | -143.29% | -0.77% | -0.77% | -0.77% | -0.78% | -0.78% |
| Total Assets | $20,266.23K | $20,266.23K | $20,266.23K | $20,266.23K | $20,266.23K | $20,266.23K |
| Net Income | -$28,220.80K | -$156.68K | -$156.85K | -$157.05K | -$157.28K | -$157.54K |